These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 10676573)

  • 1. Is there a need for blood substitutes in the new millennium and what should we expect in the way of safety and efficacy?
    Chang TM
    Artif Cells Blood Substit Immobil Biotechnol; 2000 Jan; 28(1):v-xi. PubMed ID: 10676573
    [No Abstract]   [Full Text] [Related]  

  • 2. "Is there a need for blood substitutes in the new millennium and what should we expect in the way of safety and efficacy?".
    Greenburg AG
    Artif Cells Blood Substit Immobil Biotechnol; 2000 Mar; 28(2):v-vi. PubMed ID: 10728577
    [No Abstract]   [Full Text] [Related]  

  • 3. Is there a need for blood substitutes in the new millennium and what should we expect in the way of safety and efficacy? A research perspective.
    Alayash AI
    Artif Cells Blood Substit Immobil Biotechnol; 2001 Jan; 29(1):1-3. PubMed ID: 11280680
    [No Abstract]   [Full Text] [Related]  

  • 4. "Is there a need for blood substitutes in the new millennium and what should we expect in the way of safety and efficacy?".
    Chen HS
    Artif Cells Blood Substit Immobil Biotechnol; 2000 Mar; 28(2):vii. PubMed ID: 10728578
    [No Abstract]   [Full Text] [Related]  

  • 5. "Is there a need for blood substitutes in the new millennium and what should we expect in the way of safety and efficacy?".
    Feola M; Simoni J
    Artif Cells Blood Substit Immobil Biotechnol; 2000 Mar; 28(2):vii-ix. PubMed ID: 10728579
    [No Abstract]   [Full Text] [Related]  

  • 6. "Is there a need for blood substitutes in the new millennium and what should we expect in the way of safety and efficacy?".
    Chengmin Y
    Artif Cells Blood Substit Immobil Biotechnol; 2000 Jul; 28(4):v-vi. PubMed ID: 10928698
    [No Abstract]   [Full Text] [Related]  

  • 7. "Is there a need for blood substitutes in the new millennium and what should we expect in the way of safety and efficacy?".
    Tsuchida E
    Artif Cells Blood Substit Immobil Biotechnol; 2000 May; 28(3):v-vii; discussion viii-xii. PubMed ID: 10852671
    [No Abstract]   [Full Text] [Related]  

  • 8. Is there a need for blood substitutes in the new millennium, and what should we expect in the way of safety and efficacy? A development perspective.
    Hsia CJ
    Artif Cells Blood Substit Immobil Biotechnol; 2001 May; 29(3):vii-x. PubMed ID: 11358041
    [No Abstract]   [Full Text] [Related]  

  • 9. [Past, present, future use of blood substitutes and plasma substitutes in Japan].
    Toyama H
    Masui; 1985 Apr; 34(4):515-29. PubMed ID: 4021100
    [No Abstract]   [Full Text] [Related]  

  • 10. Safety and utility of blood substitutes.
    Winslow RM
    Dev Biol (Basel); 2000; 102():167-82. PubMed ID: 10794104
    [No Abstract]   [Full Text] [Related]  

  • 11. A graded scale for assessment of safety of blood substitutes.
    Przybelski RJ; Daily EK; Stern KN; Mattia-Goldberg C
    Transfusion; 1997 Jul; 37(7):749-51. PubMed ID: 9225940
    [No Abstract]   [Full Text] [Related]  

  • 12. Future prospects for artificial blood.
    Chang TM
    Trends Biotechnol; 1999 Feb; 17(2):61-7. PubMed ID: 10087605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Standard of efficacy for red blood cell substitutes.
    Chang TM
    Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(1):vii-viii. PubMed ID: 8055093
    [No Abstract]   [Full Text] [Related]  

  • 14. Blood substitutes in surgery.
    Burris D
    Ann Chir Gynaecol; 2001; 90(2):76-80. PubMed ID: 11459262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Points to consider in the safety evaluation of hemoglobin-based oxygen carriers. Center for Biologics Evaluation and Research.
    Transfusion; 1991 May; 31(4):369-71. PubMed ID: 2021002
    [No Abstract]   [Full Text] [Related]  

  • 16. Blood substitutes and infection.
    Otto BR; Verweij-van Vught AM; MacLaren DM
    Nature; 1992 Jul; 358(6381):23-4. PubMed ID: 1614525
    [No Abstract]   [Full Text] [Related]  

  • 17. Animal sera, animal sera derivatives and substitutes used in the manufacture of pharmaceuticals. 5-6 May 1998, Strasbourg, France.
    Castle P; Robertson JS
    Biologicals; 1998 Dec; 26(4):365-8. PubMed ID: 10403041
    [No Abstract]   [Full Text] [Related]  

  • 18. What ever happened to blood substitutes?
    Stowell CP
    Transfusion; 2004 Oct; 44(10):1403-4. PubMed ID: 15383010
    [No Abstract]   [Full Text] [Related]  

  • 19. [Transfusion medicine in adults. Perspectives].
    Lapierre V; Hervé P
    Presse Med; 1999 Jul 3-10; 28(24):1336-40. PubMed ID: 10442069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Blood and hepatitis C].
    de Buren N
    Rev Med Suisse Romande; 1993 Aug; 113(8):661. PubMed ID: 8372313
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.